Literature DB >> 24880421

Top-up operation at Pohang Light Source-II.

I Hwang1, J Y Huang1, M Kim1, B-J Lee1, C Kim1, J-Y Choi1, M-H Kim1, H S Lee1, D Moon1, E H Lee1, D-E Kim1, S H Nam1, S Shin1, Moohyun Cho2.   

Abstract

After three years of upgrading work, PLS-II (S. Shin, Commissioning of the PLS-II, JINST, January 2013) is now successfully operating. The top-up operation of the 3 GeV linear accelerator had to be delayed because of some challenges encountered, and PLS-II was run in decay mode at the beginning in March 2012. The main difficulties encountered in the top-up operation of PLS-II are different levels between the linear accelerator and the storage ring, the 14 narrow gap in-vacuum undulators in operation, and the full energy injection by 3 GeV linear accelerator. Large vertical emittance and energy jitter of the linac were the major obstacles that called for careful control of injected beam to reduce beam loss in the storage ring during injection. The following measures were taken to resolve these problems: (1) The high resolution Libera BPM (see http://www.i-tech.si) was implemented to measure the beam trajectory and energy. (2) Three slit systems were installed to filter the beam edge. (3) De-Qing circuit was applied to the modulator system to improve the energy stability of injected beam. As a result, the radiation by beam loss during injection is reduced drastically, and the top-up mode has been successfully operating since 19th March 2013. In this paper, we describe the experimental results of the PLS-II top-up operation and the improvement plan.

Year:  2014        PMID: 24880421     DOI: 10.1063/1.4878256

Source DB:  PubMed          Journal:  Rev Sci Instrum        ISSN: 0034-6748            Impact factor:   1.523


  1 in total

1.  AP-XPS beamline, a platform for operando science at Pohang Accelerator Laboratory.

Authors:  Geonhwa Kim; Youngseok Yu; Hojoon Lim; Beomgyun Jeong; Jouhahn Lee; Jaeyoon Baik; Bongjin Simon Mun; Ki Jeong Kim
Journal:  J Synchrotron Radiat       Date:  2020-01-28       Impact factor: 2.616

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.